, ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin, may lead to a rise in codeine plasma concentrations with subsequently better metabolism by cytochrome P450 2D6, resulting in greater morphine levels, which could enhance or lengthen adverse reactions and could trigger most likely https://judahlnmjf.ssnblog.com/31474466/fascination-about-akorn-promethazine-codeine